ATNF Projected Dividend Yield
Com Par $0.0001/180 Life Sciences Corp ( NASDAQ : ATNF )180 Life Sciences Corp. is a clinical-stage biotechnology company focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis. Co. is primary focused on program to treat several inflammatory disorders using anti-TNF (tumor necrosis factor). Co. has three product development platforms: Anti-TNF platform, SCAs platform and a7nAChR platform. Anti-TNF platform is focused on fibrosis and anti-tumor necrosis factor (anti-TNF). SCAs platform is focused on drugs which are synthetic cannabidiol (CBD) or cannabigerol (CBG) analogues (SCAs). a7nAChR platform is focused on alpha 7 nicotinic acetylcholine receptor (a7nAChR). 20 YEAR PERFORMANCE RESULTS |
ATNF Dividend History Detail ATNF Dividend News ATNF Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |